Related references
Note: Only part of the references are listed.Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis
Ningning Niu et al.
GUT (2020)
Lgr5-positive endothelial progenitor cells occupy a tumor and injury prone niche in the kidney vasa recta
Mike R. Wilson et al.
STEM CELL RESEARCH (2020)
Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers
Rui Chen et al.
JOURNAL OF CANCER (2020)
SETD2 regulates the maternal epigenome, genomic imprinting and embryonic development
Qianhua Xu et al.
NATURE GENETICS (2019)
Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma
Jake June-Koo Lee et al.
CELL (2019)
The histone methyltransferase Setd2 is indispensable for V(D)J recombination
Zhongzhong Ji et al.
NATURE COMMUNICATIONS (2019)
Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/β-catenin signaling
Chaoying Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
SETD2 Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma
Sharadha Sakthikumar et al.
CANCER RESEARCH (2018)
The histone methyltransferase SETD2 is required for expression of acrosin-binding protein 1 and protamines and essential for spermiogenesis in mice
Xiaoli Zuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
Anna Skucha et al.
NATURE COMMUNICATIONS (2018)
H3K36 trimethylation mediated by SETD2 regulates the fate of bone marrow mesenchymal stem cells
Lijun Wang et al.
PLOS BIOLOGY (2018)
Polycystic kidney disease
Carsten Bergmann et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma
Weibin Hou et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Genetically engineered mouse models in oncology research and cancer medicine
Kelly Kersten et al.
EMBO MOLECULAR MEDICINE (2017)
Epithelial-mesenchymal transition in tumor metastasis
Kay T. Yeung et al.
MOLECULAR ONCOLOGY (2017)
Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis
Huairui Yuan et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice
Sabine Harlander et al.
NATURE MEDICINE (2017)
MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma
Sean T. Bailey et al.
NATURE COMMUNICATIONS (2017)
The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
Amrita M. Nargund et al.
CELL REPORTS (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity
Kun Chen et al.
CELL (2017)
Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma
David M. Walter et al.
CANCER RESEARCH (2017)
SETD2 histone modifier loss in aggressive GI stromal tumours
Kie Kyon Huang et al.
GUT (2016)
Deletion of Lkb1 in Renal Tubular Epithelial Cells Leads to CKD by Altering Metabolism
Seung Hyeok Han et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
Thai H. Ho et al.
MODERN PATHOLOGY (2016)
Dual Chromatin and Cytoskeletal Remodeling by SETD2
In Young Park et al.
CELL (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation
Kathryn E. Hacker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Structural basis for recognition of histone H3K36me3 nucleosome by human de novo DNA methyltransferases 3A and 3B
Gregoire Rondelet et al.
JOURNAL OF STRUCTURAL BIOLOGY (2016)
Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study
Tung-Min Yu et al.
LANCET ONCOLOGY (2016)
Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation
Sophia X. Pfister et al.
CANCER CELL (2015)
Role of DNA methylation in renal cell carcinoma
Niraj Shenoy et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma
Weisi Liu et al.
MEDICINE (2015)
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
N. Kanu et al.
ONCOGENE (2015)
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
Emelyn H. Shroff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice
Yosuke Osawa et al.
EBIOMEDICINE (2015)
VHL, the story of a tumour suppressor gene
Lucy Gossage et al.
NATURE REVIEWS CANCER (2015)
Identification of functional cooperative mutations of SETD2 in human acute leukemia
Xiaofan Zhu et al.
NATURE GENETICS (2014)
H3K36 Histone Methyltransferase Setd2 Is Required for Murine Embryonic Stem Cell Differentiation toward Endoderm
Yuanliang Zhang et al.
CELL REPORTS (2014)
Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
Adam M. Fontebasso et al.
ACTA NEUROPATHOLOGICA (2013)
The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα
Feng Li et al.
CELL (2013)
Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
Joachim Albers et al.
EMBO MOLECULAR MEDICINE (2013)
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
M. Bianchi et al.
ANNALS OF ONCOLOGY (2012)
TCF/LEFs and Wnt Signaling in the Nucleus
Ken M. Cadigan et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Generation of a Mouse Model of Von Hippel-Lindau Kidney Disease Leading to Renal Cancers by Expression of a Constitutively Active Mutant of HIF1α
Leiping Fu et al.
CANCER RESEARCH (2011)
An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway
Foster C. Gonsalves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma
Gerben Duns et al.
CANCER RESEARCH (2010)
Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling
Ming Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Kidney volume quantification using contrast-enhanced in vivo X-ray micro-CT in mice
M. Almajdub et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2008)
A primary culture of mouse proximal tubular cells, established on collagen-coated membranes
Sara Terryn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Maximizing mouse cancer models
Kristopher K. Frese et al.
NATURE REVIEWS CANCER (2007)
Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract
XL Shao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Share Paper
